RBPJ and osteosarcoma: To explore the involvement of aberrant Notch signalling in the pathogenesis of osteosarcoma, we investigated the expression of the Notch pathway molecules in osteosarcoma patient specimens and examined the effects of Notch pathway inhibition by γ-secretase inhibitor (GSI) and CBF1 siRNA.